Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03341234Completed
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Atatürk University. Primary endpoint: Total Opioid Consumption at 24 hours. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03341234.